Corpus Intelligence IC Memo — WILLAPA HARBOR HOSPITAL 2026-04-26 15:52 UTC
IC Memo — WILLAPA HARBOR HOSPITAL
Investment Committee Memorandum | WA | 10 beds | Grade D | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WILLAPA HARBOR HOSPITAL

CCN 501303 | WILLAPA, WA | 10 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

WILLAPA HARBOR HOSPITAL is a 10-bed rural/critical access in WILLAPA, WA with $26.5M in net patient revenue and a -1.1% operating margin. The hospital serves a payer mix of 70.0% Medicare, 10.5% Medicaid, and 19.4% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.1% to 6.3% (+736bps).

Net Revenue HCRIS$26.5M
Current EBITDA COMPUTED$-291K
Operating Margin COMPUTED-1.1%
Occupancy HCRIS26.0%
Revenue / Bed COMPUTED$2.7M
Net-to-Gross HCRIS61.1%
Distress Probability ML58.1%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
12
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -1.1% places it above the state median. Among 12 size-comparable peers (5-20 beds), the median margin is -9.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (5-20), prioritizing same-state peers. 12 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WILLAPA HARBOR HOSPITAL (Target)WA10$26.5M-1.1%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
SUMMIT PACIFIC MEDICAL CENTERWA10$73.6M9.1%
NEWPORT COMMUNITY HOSPITALWA20$38.6M-4.1%
KLICKITAT VALLEY HEALTHWA16$32.3M-11.7%
FORKS COMMUNITY HOSPITALWA17$31.9M-23.5%
PEACE ISLAND MEDICAL CENTERWA10$26.1M-4.5%
NORTH VALLEY HOSPITALWA18$25.9M-6.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$557K+210bp18mo
Cost to Collect4.5%2.5%$531K+200bp12mo
Denial Rate Reduction12.0%6.5%$525K+198bp12mo
A/R Days Reduction5200.0%3800.0%$323K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$557K
Cost to Collect
$531K
Denial Rate Reduction
$525K
A/R Days Reduction
$323K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$-291K
+ RCM Uplift+$2.0M
Pro Forma EBITDA$1.7M
Current Margin-1.1%
Pro Forma Margin6.3%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-448K$17.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-448K$19.2M0.00x-100.0%
Bull Case9.0x11.0x$-403K$25.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-403K$27.7M0.00x-100.0%
Bear Case11.0x10.0x$-493K$8.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-493K$8.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 70.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 26.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 12 hospitals with 5-20 beds
  • Same-state prioritization (n=15)
  • Comp margins: P25=-23.7% / P50=-9.0% / P75=-4.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.